This paper deals with the problem of continuous lyophilization of pharmaceutical products, focusing on those concepts that are of greatest interest and most likely to be successful once applied in industrial practice. Also, it discusses all those factors that slow down the transition from batch to continuous in the pharmaceutical industry, and what actions may accelerate this transformation.

Continuous manufacturing of lyophilized products: Why and how to make it happen / Pisano, R.. - In: AMERICAN PHARMACEUTICAL REVIEW. - ISSN 1099-8012. - STAMPA. - 23:3(2020), pp. 1-4.

Continuous manufacturing of lyophilized products: Why and how to make it happen

Pisano R.
2020

Abstract

This paper deals with the problem of continuous lyophilization of pharmaceutical products, focusing on those concepts that are of greatest interest and most likely to be successful once applied in industrial practice. Also, it discusses all those factors that slow down the transition from batch to continuous in the pharmaceutical industry, and what actions may accelerate this transformation.
File in questo prodotto:
File Dimensione Formato  
a-2020_APR_23(3)_1-4.pdf

non disponibili

Tipologia: 2a Post-print versione editoriale / Version of Record
Licenza: Non Pubblico - Accesso privato/ristretto
Dimensione 1.01 MB
Formato Adobe PDF
1.01 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
a-2020_APR_23(3)_1-4_(post-print).pdf

accesso aperto

Tipologia: 2. Post-print / Author's Accepted Manuscript
Licenza: PUBBLICO - Tutti i diritti riservati
Dimensione 282.07 kB
Formato Adobe PDF
282.07 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11583/2862674